Thousand Oaks, CA, United States of America

Donghui Shi

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 11.2

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Innovations of Donghui Shi in Metabolic Disorder Treatments

Introduction

Donghui Shi is a prominent inventor based in Thousand Oaks, CA (US), known for his significant contributions to the field of metabolic disorder treatments. He holds a total of 9 patents, showcasing his innovative approach to addressing various metabolic diseases.

Latest Patents

Among his latest patents, Donghui Shi has developed methods for treating or ameliorating metabolic disorders using binding proteins for the gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists. These methods target metabolic diseases such as type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels, and diabetic nephropathy. In certain embodiments, the antigen binding protein is administered alongside a GLP-1 receptor agonist. Additionally, he has patented nucleic acid molecules encoding binding proteins for GIPR, further emphasizing his focus on innovative treatments for metabolic disorders.

Career Highlights

Donghui Shi is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to explore and develop groundbreaking solutions for metabolic diseases, contributing to advancements in medical science.

Collaborations

Throughout his career, Donghui Shi has collaborated with notable colleagues, including Xiaoshan Min and Zhulun Wang. These partnerships have fostered a collaborative environment that enhances the development of innovative treatments.

Conclusion

Donghui Shi's contributions to the field of metabolic disorder treatments through his patents and collaborations highlight his role as a leading inventor in this critical area of healthcare. His work continues to pave the way for advancements in the treatment of metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…